Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-25-011209)

Filing Details

Accession Number:: 0001415889-25-011209
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-04-23 16:44:26
Reporting Period:: 2025-04-21

Filing Date:: 2025-04-23
Accepted Time:: 2025-04-23 16:44:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1730430	Kiniksa Pharmaceuticals International Plc	KNSA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1857177	Ross Moat	23 Old Bond Street, Third Floor London X0 W1S 4PZ	Chief Commercial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Ordinary Share	Disposition	2025-04-21	18,259	$20.29	9,415	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 3, 2024.
This transaction was executed in multiple trades through a broker-dealer at prices ranging between $20.05 and 20.53. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.